 Todos Medical Ltd. OTCQB:TOMDF said its majority-owned subsidiary 3CL Pharma Ltd has finished plans for a proposed safety and efficacy clinical trial for its 3CL protease inhibitor immune support dietary supplement Tollovid in patients with Long COVID. 